help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1399
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/2/509    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cappola, A. R.
Right arrow Articles by Fried, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cappola, A. R.
Right arrow Articles by Fried, L. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Seniors' Health
Hazardous Substances DB
*TESTOSTERONE
Related Collections
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 2 509-516
Copyright © 2007 by The Endocrine Society

Determinants of Serum Total and Free Testosterone Levels in Women over the Age of 65 Years

Anne R. Cappola, Sarah J. Ratcliffe, Shalender Bhasin, Marc R. Blackman, Jane Cauley, John Robbins, Joseph M. Zmuda, Tamara Harris and Linda P. Fried

Division of Endocrinology, Diabetes, and Metabolism (A.R.C.) and Center for Clinical Epidemiology and Biostatistics (A.R.C., S.J.R.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6021; Section of Endocrinology (S.B.), Boston University, Boston, Massachusetts 02118; Endocrine Section, Laboratory of Clinical Investigation, National Center for Complementary and Alternative Medicine (M.R.B.) and Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging (T.H.), National Institutes of Health, Bethesda, Maryland 20892; Department of Epidemiology (J.C., J.M.Z.), University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of General Internal Medicine (J.R.), University of California, Davis, Sacramento, California 95817; and Division of Geriatric Medicine and Gerontology and Center on Aging and Health (L.P.F.), Johns Hopkins Medical Institutions, Baltimore, Maryland 21205

Address all correspondence and requests for reprints to: Anne R. Cappola, M.D., Sc.M., Division of Endocrinology, Diabetes, and Metabolism, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 718 Blockley, 423 Guardian Drive, Philadelphia, Pennsylvania 19104-6021. E-mail: acappola{at}cceb.med.upenn.edu.

Context: Little is known about testosterone (T) levels and their determinants in women of late postmenopausal age.

Objective: We describe levels of total and free T and selected factors that influence these levels in a random sample of older women.

Design: Levels of serum total T and free T by microdialysis were measured using ultrasensitive assays in 347 community-dwelling women aged 65–98 yr enrolled in the Cardiovascular Health Study. Cross-sectional analyses were performed to define factors associated with total and free T levels.

Results: In adjusted models: 1) total T levels declined with age until 80, whereas free T levels did not vary by age; 2) women with bilateral oophorectomy had 23% lower total T and 16% lower free T levels than those with at least one intact ovary; 3) oral estrogen users had total and free T levels that were 47% lower than never users; 4) obese women had 47% higher total T and 20% higher free T levels, and overweight women had 24% higher total T and 14% higher free T levels, than normal weight women; and 5) free T levels were 51% higher in black women. Corticosteroid users had 75% lower total T and 43% lower free T levels than nonusers.

Conclusions: Bilateral oophorectomy, estrogen use, corticosteroid use, and low body mass index are independent risk factors for lower T levels in women aged 65 yr and over. Although highly prevalent in women of this age, the physiological significance of low T levels in late postmenopausal women requires further investigation.




This article has been cited by other articles:


Home page
Cancer Res.Home page
V. Mah, D. B. Seligson, A. Li, D. C. Marquez, I. I. Wistuba, Y. Elshimali, M. C. Fishbein, D. Chia, R. J. Pietras, and L. Goodglick
Aromatase Expression Predicts Survival in Women with Early-Stage Non Small Cell Lung Cancer
Cancer Res., November 1, 2007; 67(21): 10484 - 10490.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society